# A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

> **NCT02611466** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 215 (actual)

## Conditions studied

- Osteoarthritis of the Knee
- Chronic Lower Back Pain

## Interventions

- **DRUG:** ASP7962
- **DRUG:** Naproxen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02611466
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-16
- **Primary completion:** 2017-08-28
- **Final completion:** 2017-09-29
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02611466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02611466, "A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02611466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*